• LAST PRICE
    12.8700
  • TODAY'S CHANGE (%)
    Trending Down-0.1800 (-1.3793%)
  • Bid / Lots
    12.8600/ ---
  • Ask / Lots
    12.8700/ ---
  • Open / Previous Close
    13.0500 / 13.0500
  • Day Range
    Low 12.8600
    High 13.4400
  • 52 Week Range
    Low 8.5200
    High 18.8000
  • Volume
    5,922,095

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table
TimeVolumeELAN
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesELAN
Elanco Animal Health Inc
6.4B
---
---
United StatesPETQ
PetIQ Inc
663.2M
---
---
United StatesPAHC
Phibro Animal Health Corp
770.4M
---
-13.61%
United StatesSUPN
Supernus Pharmaceuticals Inc
1.6B
---
-59.02%
United StatesEGRX
Eagle Pharmaceuticals Inc
77.7M
---
-4.75%
United StatesSGTI
Shengtai Pharmaceutical Inc
10.0
---
---
As of 2024-07-19

Company Information

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Contact Information

Headquarters
2500 Innovation Way NGREENFIELD, IN, United States 46140-9163
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Lawrence Kurzius
President, Chief Executive Officer, Director
Jeffrey Simmons
Chief Financial Officer, Executive Vice President
Todd Young
Executive Vice President, General Counsel, Company Secretary
Shiv O'Neill
Executive Vice President, Human Resources, Corporate Communications and Administration
David Kinard

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.4B
Revenue (TTM)
$4.4B
Shares Outstanding
494.2M
Elanco Animal Health Inc does not pay a dividend.
Beta
1.42
EPS
$-2.64
Book Value
$12.63
P/E Ratio
---
Price/Sales (TTM)
1.5
Price/Cash Flow (TTM)
---
Operating Margin
-21.47%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.